Researchers at the Optics and Photonics Research Center (CePOF) have succeeded in increasing the susceptibility of the fungus Candida albicans to drug treatment through light-activated therapy. The ...
Researchers at the Optics and Photonics Research Center (CePOF) have succeeded in increasing the susceptibility of the fungus Candida albicans to drug treatment through light-activated therapy. The ...
Scientists have shown how the yeast Candida albicans can modulate and adapt to low oxygen levels in different body niches to cause infection and to harm the host. Studying adaption to hypoxic or ...
Drug combination therapy has the potential to extend the shelf-life of existing antimicrobial drugs by reducing the rate at which resistance evolves, but the consequences of this therapeutic approach ...
Candida albicans gilt zunehmend als Schlüssel zur Entwicklung innovativer Antimykotika. Wissenschaftler erforschen intensiv, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results